169 related articles for article (PubMed ID: 28427144)
1. Human papillomavirus infection as a prognostic marker for lung adenocarcinoma: a systematic review and meta-analysis.
Guo L; Liu S; Zhang S; Chen Q; Zhang M; Quan P; Sun X
Oncotarget; 2017 May; 8(21):34507-34515. PubMed ID: 28427144
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus infections as a marker to predict overall survival in lung adenocarcinoma.
Wang JL; Fang CL; Wang M; Yu MC; Bai KJ; Lu PC; Liu HE
Int J Cancer; 2014 Jan; 134(1):65-71. PubMed ID: 23797776
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus-related esophageal cancer survival: A systematic review and meta-analysis.
Guo L; Liu S; Zhang S; Chen Q; Zhang M; Quan P; Sun XB
Medicine (Baltimore); 2016 Nov; 95(46):e5318. PubMed ID: 27861358
[TBL] [Abstract][Full Text] [Related]
4. HPV and lung cancer: A systematic review and meta-analysis.
Karnosky J; Dietmaier W; Knuettel H; Freigang V; Koch M; Koll F; Zeman F; Schulz C
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1350. PubMed ID: 33624444
[TBL] [Abstract][Full Text] [Related]
5. HPV and lung cancer risk: a meta-analysis.
Zhai K; Ding J; Shi HZ
J Clin Virol; 2015 Feb; 63():84-90. PubMed ID: 25315992
[TBL] [Abstract][Full Text] [Related]
6. Lung adenocarcinoma and human papillomavirus infection.
Chen YC; Chen JH; Richard K; Chen PY; Christiani DC
Cancer; 2004 Sep; 101(6):1428-36. PubMed ID: 15368331
[TBL] [Abstract][Full Text] [Related]
7. Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan, China.
Fei Y; Yang J; Hsieh WC; Wu JY; Wu TC; Goan YG; Lee H; Cheng YW
Jpn J Clin Oncol; 2006 May; 36(5):274-9. PubMed ID: 16690730
[TBL] [Abstract][Full Text] [Related]
8. Infection status and survival impact of high-risk human papillomavirus in cervical adenocarcinomas: A systematic review and meta-analysis.
Chen H; Xiong W; Dong X; Liu Y; Tan X
Gynecol Oncol; 2022 Oct; 167(1):129-136. PubMed ID: 35973872
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus infection and colorectal cancer risk: a meta-analysis.
Damin DC; Ziegelmann PK; Damin AP
Colorectal Dis; 2013 Aug; 15(8):e420-8. PubMed ID: 23895733
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of human papillomavirus in colorectal adenomas and adenocarcinomas: a systematic review and meta-analysis.
Baandrup L; Thomsen LT; Olesen TB; Andersen KK; Norrild B; Kjaer SK
Eur J Cancer; 2014 May; 50(8):1446-61. PubMed ID: 24560489
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus 16/18 infections in lung cancer patients in Mexico.
Badillo-Almaraz I; Zapata-Benavides P; Saavedra-Alonso S; Zamora-Avila D; Reséndez-Pérez D; Tamez-Guerra R; Herrera-Esparza R; Rodríguez-Padilla C
Intervirology; 2013; 56(5):310-5. PubMed ID: 23942143
[TBL] [Abstract][Full Text] [Related]
12. Detection of human papillomavirus genotypes in bronchial cancer using sensitive multimetrix assay.
Syrjänen K; Silvoniemi M; Salminen E; Vasankari T; Syrjänen S
Anticancer Res; 2012 Feb; 32(2):625-31. PubMed ID: 22287755
[TBL] [Abstract][Full Text] [Related]
13. The most important questions in cancer research and clinical oncology : Question 1. Could the vertical transmission of human papilloma virus (HPV) infection account for the cause, characteristics, and epidemiology of HPV-positive oropharyngeal carcinoma, non-smoking East Asian female lung adenocarcinoma, and/or East Asian triple-negative breast carcinoma?
Wee JT; Poh SS
Chin J Cancer; 2017 Jan; 36(1):13. PubMed ID: 28093081
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: a meta analysis].
Yuanyuan X; Suling H; Quan Z; Shixun Z; Yucheng Y; Houyong K; Guohua H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Mar; 50(3):236-43. PubMed ID: 26268498
[TBL] [Abstract][Full Text] [Related]
15. Systematic review with meta-analysis: the association between human papillomavirus infection and oesophageal cancer.
Li X; Gao C; Yang Y; Zhou F; Li M; Jin Q; Gao L
Aliment Pharmacol Ther; 2014 Feb; 39(3):270-81. PubMed ID: 24308856
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis.
Zhang J; Zhang Y; Zhang Z
PLoS One; 2018; 13(9):e0204162. PubMed ID: 30256833
[TBL] [Abstract][Full Text] [Related]
17. Significance of human papillomavirus 16/18 infection in association with p53 mutation in lung carcinomas.
Yu Y; Yang A; Hu S; Zhang J; Yan H
Clin Respir J; 2013 Jan; 7(1):27-33. PubMed ID: 22171791
[TBL] [Abstract][Full Text] [Related]
18. Human papilloma virus and female lung adenocarcinoma.
Li YJ; Tsai YC; Chen YC; Christiani DC
Semin Oncol; 2009 Dec; 36(6):542-52. PubMed ID: 19995646
[TBL] [Abstract][Full Text] [Related]
19. Effects of high-risk human papillomavirus infection on P53, pRb, and survivin in lung adenocarcinoma-a retrospective study.
Sun W; Yang H; Cao L; Wu R; Ding B; Liu X; Wang X; Zhang Q
PeerJ; 2023; 11():e15570. PubMed ID: 37520249
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China.
Wang Y; Wang A; Jiang R; Pan H; Huang B; Lu Y; Wu C
Oncol Rep; 2008 Aug; 20(2):333-9. PubMed ID: 18636194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]